Comparing the Two Top Stocks: Coeur Mining, Inc. (NYSE:CDE), Myriad Genetics, Inc. (NASDAQ:MYGN)

Coeur Mining, Inc. (NYSE:CDE)

Coeur Mining, Inc. (NYSE:CDE) closed at $9.49 on the last trading session with an increase of 0.42%, whereas, it previously closed at $9.45. The company has a market capitalization of $2.65 Billion. The company traded shares of 4.2 Million on the trading day while its three month average volume stands at 4.67 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Coeur Mining, Inc. (NYSE:CDE) produced diluted EPS of -1.08. The EPS estimate for next year as estimated by analysts is at 0.57 while EPS for next quarter is estimated at 0.14. Earnings per Share growth for this year is reported at -510.8, while the analysts estimated the EPS growth for next year at 0.57% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 32.8%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Coeur Mining, Inc. (NYSE:CDE) is at 0 while the forward p/e is at 16.68. The P/S or Price to Sales ratio of Coeur Mining, Inc. (NYSE:CDE) stands at 3.53 and Price to Book or P/B for the most recent quarter stands at 3.44. The Price to Free Cash Flow ratio or P/FCF is reported at 70. The quick ratio and the current ratio of Coeur Mining, Inc. (NYSE:CDE) are reported at 0.9 and 1.2 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Coeur Mining, Inc. (NYSE:CDE) stands at -18.8, -38.9 and -34.9 respectively

The trailing twelve month Revenue of Coeur Mining, Inc. (NYSE:CDE) is reported at 752.2 Million with income of -257200000. The outstanding shares of Coeur Mining, Inc. (NYSE:CDE) are 240.98 Million. The institutional Ownership of the shares of 73.1 stands at 0.80%, this figure is increased 0.31 in the last six months. The insider ownership for the shares of Coeur Mining, Inc. (NYSE:CDE) is ticked at 0.4%, the figure is plummeted -11.28% in the last six months.

Some other important financial aspects to be discussed here for Coeur Mining, Inc. (NYSE:CDE) is the Mean Target Price estimated by the analysts which stands at 11.47. The 52 week high of Coeur Mining, Inc. (NYSE:CDE) is placed at 11.43 and 52 week low is standing at 1.98.

Performance wise the shares of Coeur Mining, Inc. (NYSE:CDE) fell down -13.57% for the week, it also rise 11.38% for the monthly performance, while for the quarter it went down 15.45%. The shares increase 64.19% for the half year and plummeted for the Year-To-Date performance. The shares of Coeur Mining, Inc. (NYSE:CDE) grew 47.59% for the yearly performance.

Myriad Genetics, Inc. (NASDAQ:MYGN)

Myriad Genetics, Inc. (NASDAQ:MYGN) closed at $24.96 on the last trading session with an decrease of -1.89%, whereas, it previously closed at $25.44. The company has a market capitalization of $1.85 Billion. The company traded shares of 1.03 Million on the trading day while its three month average volume stands at 752.97 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Myriad Genetics, Inc. (NASDAQ:MYGN) produced diluted EPS of -2.87. The EPS estimate for next year as estimated by analysts is at 0.06 while EPS for next quarter is estimated at -0.13. Earnings per Share growth for this year is reported at -250, while the analysts estimated the EPS growth for next year at 0.06% and Earnings growth for next 5 years stands at 8.1% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -35.1%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Myriad Genetics, Inc. (NASDAQ:MYGN) is at 0 while the forward p/e is at 453.82. The P/S or Price to Sales ratio of Myriad Genetics, Inc. (NASDAQ:MYGN) stands at 3.1 and Price to Book or P/B for the most recent quarter stands at 2.05. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Myriad Genetics, Inc. (NASDAQ:MYGN) are reported at 2.8 and 3 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Myriad Genetics, Inc. (NASDAQ:MYGN) stands at -13.2, -20.1 and -18.2 respectively

The trailing twelve month Revenue of Myriad Genetics, Inc. (NASDAQ:MYGN) is reported at 597.5 Million with income of -214100000. The outstanding shares of Myriad Genetics, Inc. (NASDAQ:MYGN) are 74.7 Million. The institutional Ownership of the shares of 0 stands at 0.80%, this figure is increased 0.1 in the last six months. The insider ownership for the shares of Myriad Genetics, Inc. (NASDAQ:MYGN) is ticked at 2.5%, the figure is rose 0.02% in the last six months.

Some other important financial aspects to be discussed here for Myriad Genetics, Inc. (NASDAQ:MYGN) is the Mean Target Price estimated by the analysts which stands at 17.38. The 52 week high of Myriad Genetics, Inc. (NASDAQ:MYGN) is placed at 30.13 and 52 week low is standing at 9.24.

Performance wise the shares of Myriad Genetics, Inc. (NASDAQ:MYGN) rose up 15.66% for the week, it also rise 26.76% for the monthly performance, while for the quarter it went down 83.13%. The shares increase 116.48% for the half year and flew up for the Year-To-Date performance. The shares of Myriad Genetics, Inc. (NASDAQ:MYGN) shrinked -11.27% for the yearly performance.